Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
Overview
Affiliations
Nanotechnology plays a significant role in drug development. As carriers, polymeric nanoparticles can deliver vaccine antigens, proteins, and drugs to the desired site of action. Polymeric nanoparticles with lower cytotoxicity can protect the delivered antigens or drugs from degradation under unfavorable conditions via a mucosal administration route; further, the uptake of nanoparticles by antigen-presenting cells can increase and induce potent immune responses. Additionally, nanomaterials are widely used in vaccine delivery systems because nanomaterials can make the vaccine antigen long-acting. This review focuses on some biodegradable polymer materials such as natural polymeric nanomaterials, chemically synthesized polymer materials, and biosynthesized polymeric materials, and points out the advantages and the direction of research on degradable polymeric materials. The application and future perspectives of polymeric materials as delivery carriers and vaccine adjuvants in the field of drugs and vaccines are presented. With the increase of knowledge and fundamental understandings of polymer-based nanomaterials, means of integrating some other attractive properties, such as slow release, target delivery, and alternative administration methods and delivery pathways are feasible. Polymer-based nanomaterials have great potential for the development of novel vaccines and drug systems for certain needs, including single-dose and needle-free deliveries of vaccine antigens and drugs in the future.
Chitosan, a Natural Polymer, is an Excellent Sustained-Release Carrier for Amide Local Anesthetics.
Yu Y, Long Y, Zhu Z J Pain Res. 2024; 17:3539-3551.
PMID: 39493932 PMC: 11531737. DOI: 10.2147/JPR.S480926.
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy.
Wang Y, Liu C, Fang C, Peng Q, Qin W, Yan X Nanomicro Lett. 2024; 17(1):30.
PMID: 39347944 PMC: 11442722. DOI: 10.1007/s40820-024-01533-y.
Peng X, Fang J, Lou C, Yang L, Shan S, Wang Z Acta Pharm Sin B. 2024; 14(8):3432-3456.
PMID: 39220871 PMC: 11365410. DOI: 10.1016/j.apsb.2024.05.010.
Advancing Tumor Therapy: Development and Utilization of Protein-Based Nanoparticles.
Khakpour S, Hosano N, Moosavi-Nejad Z, Farajian A, Hosano H Pharmaceutics. 2024; 16(7).
PMID: 39065584 PMC: 11279530. DOI: 10.3390/pharmaceutics16070887.
DNA aptamer-functionalized PDA nanoparticles: from colloidal chemistry to biosensor applications.
Zaw O, Shean Aye N, Daduang J, Proungvitaya S, Wongwattanakul M, Ngernyuang N Front Bioeng Biotechnol. 2024; 12:1427229.
PMID: 39045538 PMC: 11263086. DOI: 10.3389/fbioe.2024.1427229.